Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Arcus Biosciences Inc
(NY:
RCUS
)
16.65
+1.34 (+8.75%)
Official Closing Price
Updated: 4:10 PM EDT, Oct 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Arcus Biosciences Inc
< Previous
1
2
3
4
5
Next >
Arcus Biosciences Announces New Employment Inducement Grants
August 09, 2022
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Appoints Dimitry Nuyten, M.D., Ph.D. as Chief Medical Officer
August 08, 2022
From
Arcus Biosciences, Inc.
Via
Business Wire
Arcus Biosciences Reports Second Quarter 2022 Financial Results and Provides a Pipeline Update
August 03, 2022
From
Arcus Biosciences, Inc.
Via
Business Wire
Arcus Biosciences to Participate in the 13th Annual Wedbush PacGrow Healthcare Conference
July 27, 2022
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
July 26, 2022
From
Arcus Biosciences, Inc.
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
July 11, 2022
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
June 24, 2022
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
June 09, 2022
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences to Participate in the Goldman Sachs 43rd Annual Global Healthcare Conference
May 31, 2022
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
May 24, 2022
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
May 10, 2022
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Reports First Quarter 2022 Financial Results and Provides a Pipeline Update, Including from the Third Interim Analysis for the ARC-7 Study
May 09, 2022
From
Arcus Biosciences, Inc.
Via
Business Wire
Arcus Biosciences to Report First Quarter 2022 Financial Results and Pipeline Update
April 26, 2022
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
April 26, 2022
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
April 11, 2022
From
Arcus Biosciences, Inc.
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
March 24, 2022
From
Arcus Biosciences, Inc.
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
February 24, 2022
From
Arcus Biosciences, Inc.
Via
Business Wire
Arcus Biosciences Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Corporate Update
February 23, 2022
From
Arcus Biosciences, Inc.
Via
Business Wire
Arcus Biosciences to Participate in the Upcoming Investor Conferences
February 15, 2022
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
February 09, 2022
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
January 25, 2022
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
January 11, 2022
From
Arcus Biosciences, Inc.
Via
Business Wire
Arcus Biosciences Provides Update on Clinical Programs, Including Key 2022 Milestones
January 10, 2022
From
Arcus Biosciences, Inc.
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
December 24, 2021
From
Arcus Biosciences
Via
Business Wire
Gilead and Arcus Biosciences Complete Closing of Option Exercise for Three Clinical-Stage Programs and New Research Collaboration
December 21, 2021
From
Arcus Biosciences, Inc.
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
December 09, 2021
From
Arcus Biosciences, Inc.
Via
Business Wire
Taiho Pharmaceutical Exercises Option for an Exclusive License to Arcus Biosciences’ Anti-TIGIT Program in Japan and Certain Territories in Asia
November 30, 2021
From
Arcus Biosciences, Inc.
Via
Business Wire
Arcus Biosciences to Participate in the Upcoming Evercore ISI HealthCONx 2021 Conference
November 22, 2021
From
Arcus Biosciences, Inc.
Via
Business Wire
Gilead Exercises Options to Three Arcus Biosciences Clinical-Stage Programs and Adds Research Collaboration
November 18, 2021
From
Gilead Sciences, Inc.
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
November 09, 2021
From
Arcus Biosciences, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.